Vanguard Personalized Indexing Management LLC Boosts Stake in Teleflex Incorporated (NYSE:TFX)

Vanguard Personalized Indexing Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX) by 19.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 6,591 shares of the medical technology company’s stock after purchasing an additional 1,063 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Teleflex were worth $1,374,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Riverview Trust Co acquired a new stake in shares of Teleflex in the first quarter valued at $31,000. Pineridge Advisors LLC acquired a new position in Teleflex in the 4th quarter valued at about $35,000. Versant Capital Management Inc grew its position in Teleflex by 20,700.0% in the 2nd quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock valued at $44,000 after acquiring an additional 207 shares in the last quarter. Blue Trust Inc. increased its stake in Teleflex by 78.2% during the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 93 shares during the period. Finally, Quadrant Capital Group LLC lifted its position in shares of Teleflex by 67.2% during the fourth quarter. Quadrant Capital Group LLC now owns 229 shares of the medical technology company’s stock worth $57,000 after purchasing an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Royal Bank of Canada upped their target price on shares of Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research note on Friday, August 2nd. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $205.00 to $245.00 in a report on Monday, July 1st. Truist Financial boosted their target price on Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Finally, Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Stock Down 1.3 %

Teleflex stock opened at $242.50 on Monday. The stock’s fifty day moving average is $235.35 and its two-hundred day moving average is $220.48. The stock has a market cap of $11.42 billion, a PE ratio of 38.92, a P/E/G ratio of 2.23 and a beta of 1.16. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $257.85. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The firm’s revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.41 earnings per share. On average, sell-side analysts expect that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is 21.83%.

Insider Buying and Selling

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $238.93, for a total transaction of $638,898.82. Following the transaction, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.43% of the stock is owned by company insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.